Furthermore, miR-125b overexpression was shown to accelerate the oncogenicity of the BCR-ABL1 fusion protein, a hallmark of chronic myeloid leukaemia (CML) but one also observed in a subset of paediatric ALL [52]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.